Answer
Methotrexate competitively inhibits dihydrofolate reductase, preventing the reduction of folic acid to tetrahydrofolic acid needed for DNA synthesis and cellular replication.
Sources for this answer
- Methotrexate 25 mg/ml InjectionHospira UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 28Document updated
Sources checked